Prescription RequiredBilypsa 4 mg contains Saroglitazar is a prescription medication used primarily for the treatment of diabetic dyslipidemia and hypertriglyceridemia in patients with type 2 diabetes. It helps manage abnormal cholesterol and triglyceride levels while also improving insulin sensitivity.
| Generic Name | Saroglitazar |
| Manufacturer | Zydus Cadila |
| Packing | 45 Tablets |
| Prescribed For | Anti-Diabetic |
| Availability | In Stock |
As a leading supplier of high-quality generic antidiabetic medicines, we provide Bilypsa (Saroglitazar 4 mg) tablets, widely used for the treatment of diabetic dyslipidemia and hypertriglyceridemia.
We ensure safe, consistent, and timely bulk supply of medications, including Saroglitazar (Generic Lipaglyn), to hospitals, clinics, pharmacies, healthcare providers, physicians, NGOs, and authorized buyers in over 80 countries worldwide. Our global distribution network spans Latin America, Africa, Asia, Europe, the Middle East, and North America, covering key markets such as Mexico, Brazil, Colombia, Peru, Chile, UAE, Saudi Arabia, Egypt, South Africa, Namibia, Kenya, Nigeria, Singapore, Vietnam, Thailand, the Philippines, Canada, and many more.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.
